Joseph D. Khoury

Also affiliated with The University of Texas MD Anderson Cancer Center, University of Nebraska Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 23 papers. Top paper: “Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1”.

Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1

Leukemia(2022)10.1038/s41375-022-01707-w

N/A

0.666DataRank · unranked

84 citations

Naval Daver, Steffen Boettcher, Christopher P. Mill, Koji Sasaki, Christine Birdwell +11 more

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Cancer Cell(2023)10.1016/j.ccell.2023.08.013

N/A

0.646DataRank · unranked

73 citations

Camilla K. Lemvigh, Stephanie L. Deng, Nathan Dangle, Neil Ruthen, Binyamin A. Knisbacher +30 more

CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights

Leukemia Research(2022)10.1016/j.leukres.2022.106928

N/A

0.644DataRank · unranked

20 citations

Nathaniel R. Wilson, Jayastu Senapati, Minas P. Economides, Monica L. Guzman, Sattva S. Neelapu +12 more

MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas

Modern Pathology(2018)10.1038/s41379-018-0067-x

N/A

0.619DataRank · unranked

61 citations

L.Jeffrey Medeiros, Pei Lin, Wei Wang, Guilin Tang, Joseph D. Khoury +6 more

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0096

N/A

0.609DataRank · unranked

57 citations

Rafet Başar, May Daher, Hind Rafei, Ping Li, Nadima Uprety +42 more

Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma

Modern Pathology(2023)10.1016/j.modpat.2023.100326

N/A

0.533DataRank · unranked

34 citations

Frank Rojas, Xin Hu, Alejandra G. Serrano, Bo Zhu, Hong Chen +23 more

AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia

Haematologica(2021)10.3324/haematol.2021.278369

N/A

0.524DataRank · unranked

32 citations

Huaxian Ma, Prerna Malaney, Xiaorui Zhang, Marisa J.L. Aitken, Po Yee Mak +12 more

BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma

Leukemia(2021)10.1038/s41375-021-01181-w

N/A

0.510DataRank · unranked

29 citations

Christopher P. Mill, Dimuthu Perera, Christine Birdwell, Qing Deng, Haopeng Yang +13 more

Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1429

N/A

0.489DataRank · unranked

25 citations

Warren Fiskus, Naval Daver, Nathaniel R. Wilson, Farhad Ravandi, Guillermo Garcia‐Manero +19 more

Improved outcomes among newly diagnosed patients with FMS‐like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification

American Journal of Hematology(2022)10.1002/ajh.26451

N/A

0.483DataRank · unranked

24 citations

Koji Sasaki, Hagop M. Kantarjian, Naval Daver, Musa Yılmaz, Courtney D. DiNardo +13 more

Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression

Leukemia(2023)10.1038/s41375-023-02108-3

N/A

0.373DataRank · unranked

11 citations

Warren Fiskus, Tapan M. Kadia, Christopher P. Mill, Koji Sasaki, Naval Daver +13 more

Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis

Blood Cancer Journal(2021)10.1038/s41408-021-00446-y

N/A

0.360DataRank · unranked

10 citations

Guillermo Montalban‐Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A. Class, Elias Jabbour +26 more

Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)

Blood Cancer Journal(2024)10.1038/s41408-024-00981-4

N/A

0.287DataRank · unranked

4 citations

Warren Fiskus, Courtney D. DiNardo, Patrick K. Reville, John A. Davis, Christine Birdwell +10 more

Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101558

N/A

0.269DataRank · unranked

5 citations

Rafael Heinz Montoya, Hiroki Akiyama, Lauren B. Ostermann, Shayuan Khazaei, Muharrem Müftüoğlu +9 more

Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

Nature Communications(2025)10.1038/s41467-025-64666-7

N/A

0.165DataRank · unranked

2 citations

Roshia Ali, Alyssa Bouska, Dylan T. Jochum, Meghana Kesireddy, Simeon Mahov +34 more

Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL

medRxiv(2023)10.1101/2023.12.06.23299616

N/A

0.132DataRank · unranked

1 citations

Nicholas J. Short, Hagop M. Kantarjian, Ti‐Cheng Chang, Pankaj S. Ghate, Chunxu Qu +17 more

Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine

Leukemia Research(2022)10.1016/j.leukres.2022.106884

N/A

0.104DataRank · unranked

1 citations

Alexandre Bazinet, Sanam Loghavi, Marina Konopleva, Kapil N. Bhalla, Naval Daver +10 more

CellSpatialGraph: Integrate hierarchical phenotyping and graph modeling to characterize spatial architecture in tumor microenvironment on digital pathology

Software Impacts(2021)10.1016/j.simpa.2021.100156

N/A

0DataRank · unranked

4 citations

Muhammad Aminu, Siba El Hussein, Joseph D. Khoury, Jia Wu, Pingjun Chen

Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T‐Cell Lymphoma

American Journal of Hematology(2025)10.1002/ajh.27736

N/A

0DataRank · unranked

6 citations

Weiwei Zhang, Sunandini Sharma, Harald Holte, Roshani Shah, Waseem Lone +39 more

RanBALL: An Ensemble Machine Learning Framework for Accurate Subtype Identification of Pediatric B‐Cell Acute Lymphoblastic Leukemia

Advanced Intelligent Systems(2025)10.1002/aisy.202500965

N/A

0DataRank · unranked

3 citations

Hanyu Xiao, Xinchao Wu, Zhenya Tang, Joseph D. Khoury, Jieqiong Wang +2 more

Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells

Cells(2023)10.3390/cells12141880

N/A

0DataRank · unranked

8 citations

Meixian Huang, Mi-Ae Lyu, Joseph D. Khoury, Sairah Ahmed, Krina K. Patel +8 more

Mechanistic basis and efficacy of targeting the β-catenin–TCF7L2–JMJD6–c-Myc axis to overcome resistance to BET inhibitors

Blood(2020)10.1182/blood.2019002922

N/A

0DataRank · unranked

73 citations

Warren Fiskus, Christopher P. Mill, Dimuthu Perera, Taghi Manshouri, Bernardo H Lara +18 more

Germline DNMT3A mutation in familial acute myeloid leukaemia

Epigenetics(2020)10.1080/15592294.2020.1809871

N/A

0DataRank · unranked

10 citations

Hannah C. Beird, Marcos R. Estecio, Swanand Hardikar, Koichi Takahashi, Sarah A. Bannon +12 more